Gathered from investors, the funds will finish enrollment from 200 to 350 patients for the study. The Freedom Lumbar Disc implant includes a patented polymer between two metal plates and is used to allow a patient’s spine to move naturally.
AxioMed will also use the funds to expand European sales of the implant and gain regulatory approval for its Freedom Cervical Disc implant.
Read the Crain’s Cleveland Business report on the AxioMed Spine funds raised.
Read other coverage on AxioMed Spine.
-AxioMed Spine Receives Innovation Award From Cleveland Clinic
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
